Ioannis Papasavvas

About

Dr Papasavvas' Curriculum Vitae

He graduated from Medical School in the University of Ioannina in Greece. Then he started training in General Medicine in the University of Burgundy, Dijon, France. He started his specialty in Ophthalmology at the General Hospital of Patras “St Andreas”, Greece.

Dr Papasavvas finished his training in ophthalmology at the Center C of the Montchoisi clinic in Lausanne, Switzerland. He succeeded in the EBO-FMH exam and obtained his FMH title as Specialist in Ophthalmology from the Swiss Board of Medicine and is a Fellow of European Board of Ophthalmology. He completed a Fellowship in Retinal diseases, Uveitis and Intraocular inflammation in COS, Lausanne under Prof Herbort and a Fellowship in Uveitis and Intraocular Inflammation in Moorfields Eye Hospital, London, UK under Prof Pavesio.
He has authored more than 40 publications in peer-reviewed scientific journals and participated as a speaker in many Congresses.

Besides working as an Ophthalmologist in COS, he is an Honorary Fellow in Uveitis in Moorfields Eye Hospital and Assistant editor in Journal of Intraocular Inflammation.

Employment

• Moorfields Eye Hospital Fellow
  2023 - Present
• Centre for Ophthalmic Specialised Care Uveitis Consultant
  2021 - Present

Education

• University of Ioannina
  ? - 2009

Projects & Funding

Projects & funding information is unavailable.

Publications (27)

• Non-Infectious Choroiditis Subdivided into Its Diverse Pathophysiological Sub-Groups Is the Best-Known and Most Appropriate Nomenclature to Date for the Reclassification and Diagnosis of Former White Dot Entities
  Diagnostics 2026 DOI: 10.3390/diagnostics16111735
  +Save
• Blue-Light Fundus Autofluorescence (BAF), an Essential Modality for the Evaluation of Inflammatory Diseases of the Photoreceptors: An Imaging Narrative
  Diagnostics 2023 DOI: 10.3390/diagnostics13142466
  +Save
• Optical Coherence Tomography Angiography (OCT-A) in Uveitis: A Literature Review and a Reassessment of Its Real Role
  Diagnostics 2023 DOI: 10.3390/diagnostics13040601
  +Save
• Mechanisms, Pathophysiology and Current Immunomodulatory/Immunosuppressive Therapy of Non-Infectious and/or Immune-Mediated Choroiditis
  Pharmaceuticals 2022 DOI: 10.3390/ph15040398
  +Save
• Diagnosis and Treatment of Primary Inflammatory Choriocapillaropathies (PICCPs): A Comprehensive Overview
  Medicina 2022 DOI: 10.3390/medicina58020165
  +Save
• A Case of Paracentral Acute Middle Maculopathy (PAMM) Associated with Cilioretinal Artery Occlusion. The Contribution of OCT-A to the Understanding of PAMMʼs Pathophysiology
  Klinische Monatsblätter für Augenheilkunde 2022 DOI: 10.1055/a-1785-4396
  +Save
• Acute Posterior Multifocal Placoid Pigment Epitheliopathy (APMPPE): A Comprehensive Approach and Case Series: Systemic Corticosteroid Therapy Is Necessary in a Large Proportion of Cases
  Medicina 2022 DOI: 10.3390/medicina58081070
  +Save
• Diagnosis, Mechanisms, and Differentiation of Inflammatory Diseases of the Outer Retina: Photoreceptoritis versus Choriocapillaritis; A Multimodal Imaging Perspective
  Diagnostics 2022 DOI: 10.3390/diagnostics12092179
  +Save
• Benefits and Limitations of OCT-A in the Diagnosis and Follow-Up of Posterior Intraocular Inflammation in Current Clinical Practice: A Valuable Tool or a Deceiver?
  Diagnostics 2022 DOI: 10.3390/diagnostics12102384
  +Save
• Tuberculosis-related serpiginous choroiditis: aggressive therapy with dual concomitant combination of multiple anti-tubercular and multiple immunosuppressive agents is needed to halt the progression of the disease
  Journal of Ophthalmic Inflammation and Infection 2022 DOI: 10.1186/s12348-022-00282-6
  +Save